Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2005-08-16
2005-08-16
Leffers, Gerry (Department: 1636)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091400, C435S455000, C435S440000, C435S325000, C435S069100, C435S029000, C435S320100, C536S023100
Reexamination Certificate
active
06929909
ABSTRACT:
The present invention is directed to methods and compositions useful in producing cells and animals having a disruption or modification of a target gene. Vectors useful in producing these cells and animals are described. In addition, methods of screening and enriching cells comprising a targeted gene modification are provided.
REFERENCES:
patent: 5530178 (1996-06-01), Mak
patent: 5625122 (1997-04-01), Mak
patent: 5627059 (1997-05-01), Capecchi et al.
patent: WO 93/16177 (1993-08-01), None
patent: WO 94/29442 (1994-12-01), None
patent: WO 99/20780 (1999-04-01), None
Kuebler, et al. “Functional Analysis of the DNA-Packaging/Terminase Protein gp17 from Bacteriophage T4”, Journal of Molecular Biology, vol. 281, pp. 803-814, 1998.
A. Bradley et al., “Site-Directed Mutagenesis in the Mouse,” Recent Progress in Hormone Research, vol. 48, 1993, pp. 237-251.
J. Snouwaert et al., “An Animal Model for Cystic Fibrosis Made by Gene Targeting,” Science, vol. 257, Aug. 21, 1992, pp. 1083-1088.
J. Dorin et al., “Cystic Fibrosis in the Mouse by Targeted Insertional Mutagenesis,” Nature, vol. 359, Sep. 17, 1992, pp. 211-215.
A. Silva et al., “Deficient Hippocampal Long-Term Potentiation in α-Calcium-Calmodulin Kinase II Mutant Mice,” Science, vol. 257, Jul. 10, 1992, pp. 201-206.
C. M. Knudson et al., “Bax-Deficient Mice With Lymphoid Hyperplasia and Male Germ Cell Death,” Science, vol. 270, Oct. 6, 1995, pp. 96-99.
N. Wang et al., “Impaired Energy Homeostasis in C/EBPα Knockout Mice,” Science, vol. 269, Aug. 25, 1995.
K. Paigen, “A Miracle Enough: the Power of Mice,” Nature Medicine, vol. 1, No. 3, Mar. 1995, pp. 215-220.
R. Bollag et al., “Homologous Recombination in Mammalian Cells,” Annu. Rev. Genet., vol. 23, 1989, pp. 199-225.
R. Kucherlapati et al., “Homologous Recombination Between Plasmids in Mammalian Cells can be Enchanced by Treatment of Input DNA,” Proc. Natl. Acad. Sci., vol. 81, May 1984, pp. 3153-3157.
T. Doetschman et al., “Targetted Correction of a Mutant HPRT Gene in Mouse Embryonic Stem Cells,” Nature, vol. 330, No. 10, Dec. 10, 1987, pp. 576-578.
O. Smithies et al., “Insertion of DNA Sequences Into the Human Chromosomal β-Globin Locus by Homologous Recombination,” Nature, vol. 317, Sep. 19, 1985, pp. 230-234.
K. Song et al., “Accurate Modificaition of a Chromosomal Plasmid by Homologous Recombination in Human Cells,” Proc. Natl. Acad. Sci., vol. 84, Oct. 1987, pp. 6820-6824.
H. Kim et al., “Recombinant Fragment Assay for Gene Targetting Based on the Polymerase Chain Reaction,” Gene, vol. 16, No. 18, Aug. 1988, pp. 8887-8903.
E. Shesely et al., “Correction of a Human βs-Globin Gene by Gene Targeting, ” Proc. Natl. Acad. Sci., vol. 88, May 1991, pp. 4294-4298.
H. Kim et al., “Problems Encountered in Detecting a Targeted Gene by the Polymerase Chain Reaction,” Gene, vol. 103, May 1991, pp. 227-233.
M. Capecchi, “The New Mouse Genetics: Altering the Genome by Gene Targeting,” Trends in Genetics, vol. 5, No. 3, Mar. 1989, pp. 70-77.
M. Capecchi, “Altering the Genome by Homologous Recombination,” Science, vol. 244, No. 4910, Jun. 16, 1989, pp. 1288-1292.
Y. Yanagawa et al., “Enrichment and Efficient Screening of ES Cells Containing a Targeted Mutation: the use of DT-A Gene With the Polyadenylation Signal as a Negative Selection Maker,” Transgenic Research, vol. 8, Feb. 1999, pp. 215-221.
M. Hu et al., “A Combination of Derepression of thelacOperator-Repressor System With Positive Induction by Glucocorticoid and Metal Ions Provides a High-Level-Inducible Gene Expression System Based on the Human Metallothionein-IIA Promoter,” Molecular and Cellular Biology, vol. 10, No. 12, Dec. 1990, pp. 6141-6151.
M. Hu et al., “The InduciblelacOperator-Repressor System is Functional for Control of Expression of Injected DNA in Xenopus Oocytes,” Gene, vol. 62, 1988, pp. 301-313.
M. Hu et al., “The InduciblelacOperator-Repressor System is Functional in Mammalian Cells,” Cell, vol. 48, Feb. 27, 1987 pp. 555-566.
M. Hu et al., “Targeting theEscherichia coli lacRepressor to the Mammalian Cell Nucleus,” Gene, vol. 99, 1991, pp. 141-150.
G. Hannan et al., “An Engineered PGK Promoter andlacOperator-Repressor System for the Regulation of Gene Expression in Mammalian Cells,” Gene, vol. 130, 1993, pp. 233-239.
Brennan Thomas J.
Siebel Christian
Burke John E.
Deltagen Inc.
Greenberg & Traurig, LLP
Leffers Gerry
LandOfFree
Gene targeting vectors comprising conditional positive... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene targeting vectors comprising conditional positive..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene targeting vectors comprising conditional positive... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3511088